Financhill
Buy
66

CRS Quote, Financials, Valuation and Earnings

Last price:
$181.55
Seasonality move :
5.8%
Day range:
$180.74 - $185.90
52-week range:
$65.26 - $213.66
Dividend yield:
0.44%
P/E ratio:
34.73x
P/S ratio:
3.24x
P/B ratio:
5.36x
Volume:
550.4K
Avg. volume:
933.3K
1-year change:
178.74%
Market cap:
$9.2B
Revenue:
$2.8B
EPS (TTM):
$5.30

CRS Analysts' Consensus Rating

The 6 analysts providing 12-month price projections for Carpenter Technology shares anticipate an average target of $234.17, ranging from a low estimate of $150.00 to a high estimate of $300.00. This average target implies a growth of 27.21% compared to the current stock price of $184.08.

Consensus Price Target

$234.17

Highest Price Target

$300.00

Lowest Price Target

$150.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 4 4

Hold 1 1 1

Sell 1 1 1
Consensus Buy Buy Buy

CRS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock